GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SciBase Holding AB (OSTO:SCIB) » Definitions » Price-to-Free-Cash-Flow

SciBase Holding AB (OSTO:SCIB) Price-to-Free-Cash-Flow : N/A (As of May. 13, 2025)


View and export this data going back to 2015. Start your Free Trial

What is SciBase Holding AB Price-to-Free-Cash-Flow?

As of today (2025-05-13), SciBase Holding AB's share price is kr0.419. SciBase Holding AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.32. Hence, SciBase Holding AB's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for SciBase Holding AB's Price-to-Free-Cash-Flow or its related term are showing as below:

OSTO:SCIB's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 28.59
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

SciBase Holding AB's Free Cash Flow per Share for the three months ended in Dec. 2024 was kr-0.06. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was kr-0.32.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 19.40% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 29.00% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 23.90% per year.

During the past 12 years, SciBase Holding AB's highest 3-Year average Free Cash Flow per Share Growth Rate was 34.30% per year. The lowest was 5.90% per year. And the median was 22.30% per year.


SciBase Holding AB Price-to-Free-Cash-Flow Historical Data

The historical data trend for SciBase Holding AB's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciBase Holding AB Price-to-Free-Cash-Flow Chart

SciBase Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

SciBase Holding AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of SciBase Holding AB's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, SciBase Holding AB's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SciBase Holding AB's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SciBase Holding AB's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where SciBase Holding AB's Price-to-Free-Cash-Flow falls into.


;
;

SciBase Holding AB Price-to-Free-Cash-Flow Calculation

SciBase Holding AB's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.419/-0.324
=N/A

SciBase Holding AB's Share Price of today is kr0.419.
SciBase Holding AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.32.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

SciBase Holding AB  (OSTO:SCIB) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


SciBase Holding AB Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of SciBase Holding AB's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


SciBase Holding AB Business Description

Traded in Other Exchanges
N/A
Address
Landsvagen 39, Sundbyberg, Stockholm, SWE, 172 63
SciBase Holding AB is a medical technology company that develops devices for the evaluation of skin disorders such as skin cancer and atopic dermatitis. SciBase's products include Nevisense and Nevisense Go and to date, the platform addresses the areas of melanoma detection, non-melanoma skin cancer detection, and skin barrier assessment. It is the only FDA-approved device for the detection of melanoma and the only MDR-approved technology for skin cancer detection in Europe. The company operates in two segments which includes skin cancer and skin barrier assessment. Majority of the revenue is generated from skin cancer segment. Its geographical segments are Europe/Rest of the World, the United States/North America, and Asia/Oceania.

SciBase Holding AB Headlines

No Headlines